BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brenner AK, Gunnes MW. Therapeutic Targeting of the Anaplastic Lymphoma Kinase (ALK) in Neuroblastoma-A Comprehensive Update. Pharmaceutics 2021;13:1427. [PMID: 34575503 DOI: 10.3390/pharmaceutics13091427] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Pulido R, Nunes-xavier CE. Hopes on immunotherapy targeting B7-H3 in neuroblastoma. Translational Oncology 2023;27:101580. [DOI: 10.1016/j.tranon.2022.101580] [Reference Citation Analysis]
2 Gonzalez Malagon SG, Liu KJ. Linking neural crest development to neuroblastoma pathology. Development 2022;149. [DOI: 10.1242/dev.200331] [Reference Citation Analysis]
3 Chilamakuri R, Rouse DC, Yu Y, Kabir AS, Muth A, Yang J, Lipton JM, Agarwal S. BX-795 inhibits neuroblastoma growth and enhances sensitivity towards chemotherapy. Transl Oncol 2022;15:101272. [PMID: 34823094 DOI: 10.1016/j.tranon.2021.101272] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]